News

Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease

F. Hoffmann-La Roche Ltd - June 16, 2022

Could drugs prevent Alzheimer’s? These trials aim to find out

Nature - Mar 9, 2022

Blood test for Alzheimer’s highly accurate in large, international study

The Source, Washington University in St. Louis - Feb 22, 2022

First Subject Enrolled in Phase II/III Study of Eisai’s Anti-MTBR Tau Antibody E2814 for Dominantly Inherited Alzheimer’s Disease (DIAD), conducted by DIAN-TU

Eisai Co., Ltd. - Jan 19 2022

New Alzheimer’s prevention trial in young people

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021

$11.5 million commitment supports new Alzheimer’s prevention clinical trial

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021

International Alzheimer’s clinical trial to test two drugs in combination

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - NOV 8 2021

Global Incubator Seed Grants awarded

The Source, Washington University in St. Louis - Sept 23, 2021

The Search for a Drug to End Alzheimer’s

Some antiamyloids remove target plaques from the brain, yet don't seem to halt cognitive decline. Researchers are working to understand...

IEEE Pulse

Aiming at the Tangle’s Heart? DIAN-TU Trial to Torpedo Tau’s Core

ALZFORUM - MAR 18, 2021